1. B07: SAFETY AND EFFICACY OF CILTACABTAGENE AUTOLEUCEL, A CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY DIRECTED AGAINST B-CELL MATURATION ANTIGEN IN PATIENTS WITH MULTIPLE MYELOMA AND EARLY RELAPSE AFTER INITIAL THERAPY: CARTITUDE-2 RESULTS. (5th April 2022) Authors: van de Donk, NWCJ; Delforge, M; Agha, M; Cohen, AD; Cohen, YC; Hillengass, J; Anguille, S; Kerre, T; Roeloffzen, W; Schecter, JM; De Braganca, KC; Varsos, H; Wang, L; Vogel, M; Zudaire, E; Corsale, C; Akram, M; Geng, D; Nesheiwat, T; Pacaud, L Journal: HemaSphere Issue: Volume 6(2022)Supplement 2 Page Start: 9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗